Eli Lilly testing arthritis drug for COVID-19 treatment
Baricitinib, also known under the brand name Olumiant, is approved in more than 65 countries as a treatment for adults with moderately to severely active rheumatoid arthritis.
Life Science & Biotech
Articles
Crowne Plaza near Indy airport being used as COVID-19 treatment site
State officials declined to provide details on specifically how the hotel is being used—including whether it is a treatment site for homeless individuals—to protect patient privacy.
First 16 Tech office building set to open in June; Innovation Hub to follow
The long-planned $500 million project is at a pivotal moment—one its organizers say could serve as a catalyst for tremendous growth at the 50-acre campus and for central Indiana overall.
Indiana ranks 7th worst among states for adults with unmet mental health needs
Indiana has been undergoing a huge shift in psychiatric care in recent years, but still doesn’t have the resources to deal with patients suffering from ailments ranging from anxiety to schizophrenia.
Butler researchers point to way to stop deadly coronavirus from spreading
Dr. Christopher Stobart and his students are focusing on an enzyme in the virus that could inhibit its replication, and plan to submit the findings to a virology journal in coming months.
Corteva Agriscience to stop making pesticide linked to brain damage
The main manufacturer of a pesticide used for decades on a wide array of crops, including strawberries, corn and citrus, said Thursday it will stop making the product, which some activists have said is linked to neurological problems in children.
Report: Indiana should boost spending on public health, establish all-payer claims database
The report, issued Monday by researchers at the Fairbanks School of Public Health at IUPUI, is the latest commentary on Indiana’s poor report card on health care.
Lilly kills R&D deal in speed bump on quest to become big cancer player
The Indianapolis drugmaker quietly terminated a collaboration with NextCure Inc. after spending $40 million on an up-front fee and equity investment, and with little to show from the partnership.
Indiana life science companies raise $74 million in venture capital, down 36%
After raking in record amounts of venture capital funding in 2017 and 2018, Indiana life science companies saw funding drop last year by double-digits, while the average deal amount dipped sharply as well.
Renowned research leader Shekhar leaving IU School of Medicine for Pitt dean’s job
Dr. Anantha Shekhar, a nationally recognized health sciences researcher and entrepreneur, has played a major role in boosting research funding at IU, where he has worked since 1989 in numerous leadership roles.
Top 10 stories for 2019 in Indiana health care and life sciences
The year didn’t feature any hostile takeovers or huge disasters. But a lot of companies made big strides in 2019, including Eli Lilly and Co., Corteva and Elanco. And many rejoiced when Washington ended a 2.3% tax on thousands of medical devices.
Medical device tax is history, ending years of frustration for Indiana companies
The repeal ends a 2.3% tax on thousands of medical devices, from stents and catheters to pacemakers and MRI machines. Indiana is home to 155 device-makers, ranging from small metal shops to multibillion-dollar manufacturers.
North America trade pact contains rare setback for Big Pharma
To satisfy House Democrats, the Trump administration removed a provision that would have given the makers of ultra-expensive biologic drugs 10 years of protection from less expensive knockoffs.
Anthem shoots down speculation over physician practices
CEO Gail Boudreaux’s recent comments at a health care summit dampened speculation that Anthem might create its own physician group, something the insurer tried unsuccessfully two decades ago.
South Bend company to open second psychiatric hospital in central Indiana
Neuropsychiatric Hospitals LLC said it is developing a 64-bed hospital in Greenwood that will serve patients with complex medical and psychiatric condition.
Fishers ag-tech firm that had big growth plans files for bankruptcy
Fishers-based Aggressively Organic Inc., an agricultural technology company that focuses on alleviating food insecurity, announced plans in 2017 to hire 200 people by the end of 2021.
New behavioral health hospital planned for Greenwood
Medistar Corp. of Texas has filed an application to build a 42,610-square-foot building at 795 North Emerson Avenue, a vacant and undeveloped site about a mile south of Franciscan Health Indianapolis.
Ascension St. Vincent expands Indianapolis cancer center
The expansion is the latest move by a large Indianapolis health system to expand cancer care, a fast-growing and competitive medical field.
Investor interest keeps Cornerstone busy in medical office building market
Indianapolis-based Cornerstone Cos. has invested more than $84 million in recent years to buy medical office buildings, clinics and surgery centers. Now it is about to start its fifth investment fund.
Implant maker Nexxt Spine to double size of Noblesville headquarters, add 25 jobs
The company said it needs more space after acquiring six laser beam printers. In the past decade, more than 600 spine surgeons have performed procedures using Nexxt Spine products.